KBC Group NV Cuts Stock Position in Mettler-Toledo International, Inc. $MTD

KBC Group NV decreased its stake in shares of Mettler-Toledo International, Inc. (NYSE:MTD) by 43.6% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,460 shares of the medical instruments supplier’s stock after selling 5,000 shares during the quarter. KBC Group NV’s holdings in Mettler-Toledo International were worth $7,589,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Bank of New York Mellon Corp grew its holdings in Mettler-Toledo International by 71.3% during the second quarter. Bank of New York Mellon Corp now owns 904,264 shares of the medical instruments supplier’s stock worth $1,062,257,000 after acquiring an additional 376,419 shares during the period. Alliancebernstein L.P. grew its stake in shares of Mettler-Toledo International by 21.6% in the first quarter. Alliancebernstein L.P. now owns 709,328 shares of the medical instruments supplier’s stock worth $837,653,000 after acquiring an additional 126,147 shares in the last quarter. PineStone Asset Management Inc. raised its stake in Mettler-Toledo International by 41.9% in the second quarter. PineStone Asset Management Inc. now owns 334,349 shares of the medical instruments supplier’s stock valued at $392,766,000 after buying an additional 98,737 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Mettler-Toledo International by 42.0% during the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 305,722 shares of the medical instruments supplier’s stock worth $361,030,000 after buying an additional 90,395 shares during the last quarter. Finally, Nuveen LLC acquired a new stake in shares of Mettler-Toledo International during the first quarter worth $71,897,000. 95.07% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, insider La Guerroniere Marc De sold 6,880 shares of the company’s stock in a transaction on Tuesday, November 11th. The shares were sold at an average price of $1,450.00, for a total value of $9,976,000.00. Following the completion of the sale, the insider owned 187 shares in the company, valued at $271,150. This represents a 97.35% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Patrick Kaltenbach sold 2,000 shares of the firm’s stock in a transaction on Wednesday, November 12th. The shares were sold at an average price of $1,462.50, for a total value of $2,925,000.00. Following the sale, the chief executive officer directly owned 3,670 shares of the company’s stock, valued at approximately $5,367,375. This represents a 35.27% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 11,549 shares of company stock worth $16,736,223 over the last three months. Company insiders own 1.94% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have weighed in on the stock. Stifel Nicolaus lifted their price target on shares of Mettler-Toledo International from $1,450.00 to $1,600.00 and gave the company a “buy” rating in a report on Monday, November 10th. Weiss Ratings reiterated a “hold (c)” rating on shares of Mettler-Toledo International in a research report on Wednesday, October 8th. Bank of America boosted their target price on Mettler-Toledo International from $1,260.00 to $1,390.00 and gave the company a “neutral” rating in a research note on Monday, September 22nd. Robert W. Baird lifted their price target on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a “neutral” rating in a research report on Monday, August 4th. Finally, JPMorgan Chase & Co. increased their price objective on Mettler-Toledo International from $1,200.00 to $1,285.00 and gave the stock a “neutral” rating in a research note on Thursday, October 9th. Five analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. Based on data from MarketBeat.com, Mettler-Toledo International presently has a consensus rating of “Hold” and an average target price of $1,406.50.

Mettler-Toledo International Stock Performance

Shares of NYSE MTD opened at $1,404.27 on Friday. The stock has a market cap of $28.69 billion, a P/E ratio of 35.56, a price-to-earnings-growth ratio of 4.19 and a beta of 1.41. Mettler-Toledo International, Inc. has a 52-week low of $946.69 and a 52-week high of $1,471.06. The firm has a 50 day moving average price of $1,334.60 and a two-hundred day moving average price of $1,248.36.

Mettler-Toledo International (NYSE:MTD) last released its earnings results on Thursday, November 6th. The medical instruments supplier reported $11.15 EPS for the quarter, topping the consensus estimate of $10.62 by $0.53. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.The business had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $997.36 million. During the same quarter last year, the firm posted $10.21 earnings per share. The firm’s revenue was up 7.9% on a year-over-year basis. Mettler-Toledo International has set its Q4 2025 guidance at 12.680-12.880 EPS. FY 2025 guidance at 42.050-42.250 EPS. Analysts predict that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current fiscal year.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.